Clinical Trial Update: Influence of a Prematuration Culture With a Phosphodiesterase-3 Inhibitor (PDE3-I) on Embryonic Aneuploidy Rate and Developmental Potential [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating a prematuration embryo culture with a phosphodiesterase-3 inhibitor for effects on embryonic aneuploidy and developmental potential; th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• PDE3 inhibitor (unspecified) (phosphodiesterase-3 inhibitor)

Snippet

Sponsor: Universitair Ziekenhuis Brussel | Conditions: Infertility | Phase 1 | Status: TERMINATED